Dott.ssa Sara Galluzzo

MD Campus Bio-Medico University, PhD UCBM/ Columbia University (NY). Medical Director at the Italian Medicines Agency, Medicines Innovation and Strategy Sector, Centralized Procedures Office. Delegate at the EMA (European Task Force for the development and evaluation of drugs and vaccines for SARS-CoV2 / Member of the Scientific Advice Working Party / Member of the PDCO). Senior consultant for WHO for biotechnology products. In AIFA she collaborate with the Research and Clinical Trials Office; with the Health Technology Assessment office in support of the Technical-Scientific Commission and the Price and Reimbursement Committee. She was an "observer" for AIFA at the Phase I Commission of the Istituto Superiore di Sanità (2015-2017).